0001415889-24-018309.txt : 20240627 0001415889-24-018309.hdr.sgml : 20240627 20240627160329 ACCESSION NUMBER: 0001415889-24-018309 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240627 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bradley Mark Christopher CENTRAL INDEX KEY: 0002023657 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42143 FILM NUMBER: 241078990 MAIL ADDRESS: STREET 1: C/O ALUMIS INC. STREET 2: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALUMIS INC. CENTRAL INDEX KEY: 0001847367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-231-6625 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ESKER THERAPEUTICS, INC. DATE OF NAME CHANGE: 20230427 FORMER COMPANY: FORMER CONFORMED NAME: FL2021-001, Inc. DATE OF NAME CHANGE: 20210222 3 1 form3-06272024_080626.xml X0206 3 2024-06-27 0 0001847367 ALUMIS INC. ALMS 0002023657 Bradley Mark Christopher C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Development Officer Class A Common Stock 21978 D Class A Common Stock 20026 I By GRAT Class A Common Stock 20026 I By GRAT Stock Option (Right to Buy) 8.84 2032-01-26 Class A Common Stock 130481 D Stock Option (Right to Buy) 8.84 2032-01-26 Class A Common Stock 128342 D Stock Option (Right to Buy) 8.84 2033-06-22 Class A Common Stock 12834 D Stock Option (Right to Buy) 8.84 2033-10-08 Class A Common Stock 23093 D Stock Option (Right to Buy) 10.2 2034-05-05 Class A Common Stock 155304 D Stock Option (Right to Buy) 13.33 2034-06-05 Class A Common Stock 53475 D Shares are held directly by JB 2023 GRAT, for which Reporting Person serves as a trustee. Shares are held directly by MB 2023 GRAT, for which Reporting Person serves as a trustee. 25% of the shares underlying this option vested on January 27, 2023, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. 33% of the shares underlying this option vested on January 27, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 48 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. 25% of the shares underlying this option vested on May 22, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. 25% of the shares underlying this option vest on October 9, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. The option vests in three equal installments, subject to the Issuer's satisfaction of certain performance criteria on each of May 6, 2028, May 6, 2029 and May 6, 2030, and subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. 25% of the shares underlying this option vest on June 6, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date. /s/ Sara Klein, Attorney-in-Fact 2024-06-27 EX-24 2 ex24-06272024_080628.htm ex24-06272024_080628.htm

POWER OF ATTORNEY


Date: 6/20//2024


Know all by these presents, that the undersigned hereby constitutes and appoints Roy Hardiman, John Schroer and Sara Klein of Alumis Inc., or any of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:


1. prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;


2. execute for and on behalf of the undersigned with respect to the Company, Schedules 13D and 13G and Forms 3, 4, and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;


3. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedules 13D or 13G or Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and


4. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.


The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming any of the undersigned's responsibilities to comply with Sections 13 and 16 of the Securities Exchange Act of 1934.


This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date first written above.




/s/ Mark Bradley


Printed Name: Mark Bradley